comparemela.com

Page 6 - Huadong Medicine Co Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure

DGAP-News: Heidelberg Pharma AG / Key word: Corporate Action Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure 30.08.2022 / 17:41 CET/CEST The issuer.

Baden wübergSylvia wimmerHeidelberg pharmaMc servicesFrankfurt stock exchangeUnited statesBaader bankRegister at mannheim local courtHuadong medicine co ltdGmbh coCorporate communicationsHeidelberg pharma research gmbFrom capitalHuadong investmentCommercial registerMannheim local court

DGAP-News: Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million

DGAP-News: Heidelberg Pharma AG / Key word(s): Corporate Action Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million .

Sylvia wimmerHeidelberg pharmaGerman federal financial supervisory authority bafinMc servicesFrankfurt stock exchangeUnited statesBaader bankHuadong medicine co ltdGmbh coCorporate communicationsHeidelberg pharma research gmbRights issueManagement boardSupervisory boardGerman federal financial supervisory authorityAuthorized capital

Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million

12.08.2022 Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million | Heidelberg Pharma AG | News | Nachricht | Mitteilung

Sylvia wimmerHeidelberg pharmaGerman federal financial supervisory authority bafinMc servicesFrankfurt stock exchangeUnited statesBaader bankHuadong medicine co ltdGmbh coCorporate communicationsHeidelberg pharma research gmbRights issueManagement boardSupervisory boardGerman federal financial supervisory authorityAuthorized capital

DGAP-News: Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

DGAP-News: Heidelberg Pharma AG / Key word(s): Half Year Report Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 20.

United statesHong kongTel avivSri lankaUnited kingdomSouth koreaSouth australiaRepublic ofRepublic of chinaTaiwan generalMacau generalSylvia wimmerJan schmidtHeidelberg pharmaHeidelberg pharma groupRedhill biopharma ltd

Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022

12.07.2022 Heidelberg Pharma AG: Heidelberg Pharma Reports on First Half-Year 2022 | Heidelberg Pharma AG | News | Nachricht | Mitteilung

United statesHong kongTel avivSri lankaUnited kingdomSouth koreaSouth australiaRepublic ofRepublic of chinaTaiwan generalMacau generalSylvia wimmerJan schmidtHeidelberg pharmaHeidelberg pharma groupRedhill biopharma ltd

vimarsana © 2020. All Rights Reserved.